Clinical features of pulmonary mucormycosis in patients with different immune status | Zendy

Min Peng | Zendy; Hua Meng | Zendy; Ying Sun | Zendy; Yu Xiao | Zendy; Hong Zhang | Zendy; Ke Lv | Zendy; Baiqiang Cai | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical features of pulmonary mucormycosis in patients with different immune status

Author(s) -

Min Peng,

Hua Meng,

Ying Sun,

Yu Xiao,

Hong Zhang,

Ke Lv,

Baiqiang Cai

Publication year - 2019

Publication title -

journal of thoracic disease

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.682

H-Index - 60

eISSN - 2077-6624

pISSN - 2072-1439

DOI - 10.21037/jtd.2019.12.53

Subject(s) - medicine , halo sign , mucormycosis , malignancy , diabetes mellitus , sputum , medical record , gastroenterology , tuberculosis , surgery , lung , pathology , endocrinology

Pulmonary mucormycosis (PM) is a relatively rare but often fatal and rapidly progressive disease. Most studies of PM are case reports or case series with limited numbers of patients, and focus on immunocompromised patients. We investigated the clinical manifestations, imaging features, treatment, and outcomes of patients with PM with a focus on the difference in clinical manifestations between patients with different immune status.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research